121 related articles for article (PubMed ID: 9089405)
1. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses.
Beppu Y; Imamura Y; Tashiro M; Towatari T; Ariga H; Kido H
J Biochem; 1997 Feb; 121(2):309-16. PubMed ID: 9089405
[TBL] [Abstract][Full Text] [Related]
2. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
[TBL] [Abstract][Full Text] [Related]
3. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
Kido H; Niwa Y; Beppu Y; Towatari T
Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of proteolytic activation of Sendai virus infection and the defensive compounds for infection.
Kido H; Beppu Y; Sakai K; Towatari T
Biol Chem; 1997; 378(3-4):255-63. PubMed ID: 9165079
[TBL] [Abstract][Full Text] [Related]
5. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.
Tashiro M; Yokogoshi Y; Tobita K; Seto JT; Rott R; Kido H
J Virol; 1992 Dec; 66(12):7211-6. PubMed ID: 1331518
[TBL] [Abstract][Full Text] [Related]
6. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.
Kido H; Murakami M; Oba K; Chen Y; Towatari T
Mol Cells; 1999 Jun; 9(3):235-44. PubMed ID: 10420980
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus.
Kido H; Sakai K; Kishino Y; Tashiro M
FEBS Lett; 1993 May; 322(2):115-9. PubMed ID: 8387030
[TBL] [Abstract][Full Text] [Related]
8. Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells.
Sakai K; Kohri T; Tashiro M; Kishino Y; Kido H
Eur Respir J; 1994 Apr; 7(4):686-92. PubMed ID: 8005249
[TBL] [Abstract][Full Text] [Related]
9. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization.
Chen Y; Shiota M; Ohuchi M; Towatari T; Tashiro J; Murakami M; Yano M; Yang B; Kido H
Eur J Biochem; 2000 Jun; 267(11):3189-97. PubMed ID: 10824103
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs.
Tashiro M; Beppu Y; Sakai K; Kido H
Arch Virol; 1996; 141(8):1571-7. PubMed ID: 8856034
[TBL] [Abstract][Full Text] [Related]
11. Electron immunohistochemical localization in rat bronchiolar epithelial cells of tryptase Clara, which determines the pneumotropism and pathogenicity of Sendai virus and influenza virus.
Sakai K; Kawaguchi Y; Kishino Y; Kido H
J Histochem Cytochem; 1993 Jan; 41(1):89-93. PubMed ID: 8380186
[TBL] [Abstract][Full Text] [Related]
12. Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.
Hochstrasser K; Gebhard W; Albrecht G; Rasp G; Kastenbauer E
Eur Arch Otorhinolaryngol; 1993; 249(8):455-8. PubMed ID: 8442939
[TBL] [Abstract][Full Text] [Related]
13. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus.
Murakami M; Towatari T; Ohuchi M; Shiota M; Akao M; Okumura Y; Parry MA; Kido H
Eur J Biochem; 2001 May; 268(10):2847-55. PubMed ID: 11358500
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein.
Kido H; Yokogoshi Y; Sakai K; Tashiro M; Kishino Y; Fukutomi A; Katunuma N
J Biol Chem; 1992 Jul; 267(19):13573-9. PubMed ID: 1618859
[TBL] [Abstract][Full Text] [Related]
15. Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.
Kido H; Okumura Y; Yamada H; Mizuno D; Higashi Y; Yano M
Biol Chem; 2004 Nov; 385(11):1029-34. PubMed ID: 15576322
[TBL] [Abstract][Full Text] [Related]
16. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
17. [Host cellular proteases trigger the infectivity of the influenza virus in the airway and brain].
Kido H; Chen Y; Yamada H; Okumura Y
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):45-53. PubMed ID: 12843572
[TBL] [Abstract][Full Text] [Related]
18. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Shimotai Y; Hatachi Y; Lusamba Kalonji N; Tando Y; Kitajima Y; Matsuo K; Kubo H; Nagatomi R; Hongo S; Homma M; Nishimura H
Pulm Pharmacol Ther; 2015 Aug; 33():66-74. PubMed ID: 26166259
[TBL] [Abstract][Full Text] [Related]
19. A novel influenza A virus activating enzyme from porcine lung: purification and characterization.
Sato M; Yoshida S; Iida K; Tomozawa T; Kido H; Yamashita M
Biol Chem; 2003 Feb; 384(2):219-27. PubMed ID: 12675514
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
